Cargando…

Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy

Modern radiotherapy (RT) techniques are widely used in the irradiation of moving organs. A crucial step in ensuring the correct position of a target structure directly before or during treatment is daily image guidance by computed tomography (CT) or X-ray radiography (image-guided radiotherapy, IGRT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habermehl, Daniel, Henkner, Katrin, Ecker, Swantje, Jäkel, Oliver, Debus, Jürgen, Combs, Stephanie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Image-Guided Radiotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700523/ https://www.ncbi.nlm.nih.gov/pubmed/23824129 http://dx.doi.org/10.1093/jrr/rrt071

Ejemplares similares

Analysis of inter- and intrafraction accuracy of a commercial thermoplastic mask system used for image-guided particle radiation therapy
por: Amelio, Dante, et al.
Publicado: (2013)

Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas
por: Kosaki, Katsura, et al.
Publicado: (2012)

Experimental Comparison of Fiducial Markers Used in Proton Therapy: Study of Different Imaging Modalities and Proton Fluence Perturbations Measured With CMOS Pixel Sensors
por: Reidel, Claire-Anne, et al.
Publicado: (2022)

The impact of particle radiotherapy on the functioning of cardiac implantable electronic devices: a systematic review of in vitro and in vivo studies according to PICO criteria
por: Barcellini, Amelia, et al.
Publicado: (2022)

P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16
por: Oertel, Michael, et al.
Publicado: (2022)

Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach
por: Boldrini, Luca, et al.
Publicado: (2018)

P092: Estimating the dosimetric benefit of involved-node radiotherapy in comparison to involved-field radiotherapy - implications from the GHSG HD 17 trial
por: Oertel, Michael, et al.
Publicado: (2022)

Impact of COVID-19 on workload burden of a complex radiotherapy facility
por: Francolini, Giulio, et al.
Publicado: (2021)

A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group
por: De Felice, Francesca, et al.
Publicado: (2020)

Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy
por: Chang, Joe H., et al.
Publicado: (2016)

Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer
por: Seppälä, Jan, et al.
Publicado: (2016)

Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis
por: Francolini, Giulio, et al.
Publicado: (2022)

Real world experience of hypofractionated radical radiotherapy for non-small cell lung cancer (NSCLC) during the COVID-19 pandemic: a well-tolerated radiotherapy schedule with acceptable progression-free (PFS) and overall survival (OS)
por: Jeyin, Nidhish, et al.
Publicado: (2023)

Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model
por: Cellini, Francesco, et al.
Publicado: (2021)

ESTRO vision 2030: the young Italian Association of Radiotherapy and Clinical Oncology (yAIRO) commitment statement
por: De Felice, Francesca, et al.
Publicado: (2021)

Changes in Tumor Volumes and Spatial Locations Relative to Normal Tissues During Cervical Cancer Radiotherapy Assessed by Cone Beam Computed Tomography
por: Chen, Wenjuan, et al.
Publicado: (2017)

Stereotactic ablative body radiotherapy (SABR) lung fractionations locally in the COVID-19 era and the impact on dosimetry, resources, early toxicities, and the environment
por: Phelps, Lyndsey, et al.
Publicado: (2021)

EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates
por: Lancellotta, Valentina, et al.
Publicado: (2022)

P096: Polymorphisms in SETD7 may predispose the risk of developing late cardiac side effects after radiotherapy including the mediastinum in Hodgkin’ s lymphoma.
por: Linderoth, Johan, et al.
Publicado: (2022)

Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)
por: Francolini, Giulio, et al.
Publicado: (2022)

Magnetic resonance-guided stereotactic body radiation therapy (MRgSBRT) for oligometastatic patients: a single-center experience
por: Chiloiro, Giuditta, et al.
Publicado: (2023)

Optimization of carbon ion and proton treatment plans using the raster-scanning technique for patients with unresectable pancreatic cancer
por: Dreher, Constantin, et al.
Publicado: (2015)

Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region
por: De Felice, Francesca, et al.
Publicado: (2020)

Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
por: Detti, Beatrice, et al.
Publicado: (2021)

Impact on mental health of the COVID-19 pandemic in a radiation oncology department
por: Caliandro, Morena, et al.
Publicado: (2022)

P091: Early analysis of the PRO-Hodgkin study: Clinical investigation of pencil beam scanning proton treatment in Hodgkin lymphoma patients
por: Goldkuhl, Christina, et al.
Publicado: (2022)

P093: From involved- field to involved-node – Quality analysis of the radiation therapy in HD 17 by the expert panel of the German Hodgkin Study Group
por: Oertel, Michael, et al.
Publicado: (2022)

P094: Long-term outcomes of bulky classic Hodgkin lymphoma managed with a PET-adapted approach demonstrate excellent outcomes in PET-negative cases
por: Kim, Jowon Laura, et al.
Publicado: (2022)

P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in England
por: Jones, David, et al.
Publicado: (2022)

Pattern of care for re-irradiation in locally recurrent rectal cancer: a national survey on behalf of the AIRO gastrointestinal tumors study group
por: Mantello, Giovanna, et al.
Publicado: (2023)

Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma
por: El Shafie, Rami A., et al.
Publicado: (2018)

Optimization of Carbon Ion Treatment Plans by Integrating Tissue Specific α/β-Values for Patients with Non-Resectable Pancreatic Cancer
por: Dreher, Constantin, et al.
Publicado: (2016)

Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) – the ESMERALDA trial
por: Habermehl, Daniel, et al.
Publicado: (2015)

Fiducial markers in prostate cancer image-guided radiotherapy
por: Ghaffari, Hamed, et al.
Publicado: (2019)

Automated fiducial marker detection and localization in volumetric computed tomography images: a three-step hybrid approach with deep learning
por: Regodić, Milovan, et al.
Publicado: (2021)

Uncertainties in estimating heart doses from 2D-tangential breast cancer radiotherapy
por: Lorenzen, Ebbe L., et al.
Publicado: (2016)

30 day mortality in adult palliative radiotherapy – A retrospective population based study of 14,972 treatment episodes
por: Spencer, Katie, et al.
Publicado: (2015)

Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT)
por: Murray, Louise J., et al.
Publicado: (2014)

Nondeformed Ultrasound Image Production Method for Ultrasound-Guided Radiotherapy
por: Li, Qixuan, et al.
Publicado: (2023)

Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_c7osd2cbqqlgne5cmvatlob949